Welcome to our dedicated page for Agape ATP SEC filings (Ticker: ATPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agape ATP Corporation filings document its public-company reporting, Nasdaq listing compliance, material agreements, shareholder votes, governance matters, and capital-structure activity. Recent Form 8-K reports cover Nasdaq continued-listing notices and regained compliance, entry into energy-sector collaboration agreements through ATPC Green Energy Sdn. Bhd., and annual meeting voting results.
The company's proxy materials describe director elections, auditor ratification, Nasdaq-related share issuance approval, and charter matters. Its reporting record also includes annual-report timing disclosure on Form 12b-25, together with recurring disclosures on operating and financial results, risk, governance, and securities matters.
Agape ATP Corporation reported Q2 2026 results showing a sharp contraction in operating activity but a small profit driven by non-operating items and discontinued operations. Continuing-operations revenue for the three and six months ended June 30, 2026 was $13,693 and $35,281, respectively, down significantly from $207,029 and $243,820 a year earlier. Despite this, a large net exchange gain and other income lifted income from continuing operations to $83,591 for Q2 2026, versus a loss in 2025. Including a $65,846 profit from discontinued operations, Q2 2026 net income reached $149,437, compared with a $623,246 net loss in Q2 2025.
For the first half of 2026 the company still recorded a net loss of $191,469, though this was smaller than the prior-year loss. Cash and cash equivalents were only $45,480 at June 30, 2026, and operating activities used $505,088 of cash in the first half. Total assets were $25.0 million, dominated by $24.5 million of deposits paid to Bi Cheng Investment Management Limited for yet-to-be-identified investments, whose returns are described as uncertain. Management states these conditions raise substantial doubt about the ability to continue as a going concern.
During the quarter, the company disposed of its 60% stake in DSY Wellness, which is now reported as discontinued operations, and continues to position its core Malaysian health and wellness business alongside emerging renewable energy and digital wellness initiatives.
Agape ATP Corporation, a Nevada holding company focused on health, wellness and emerging green energy, is conducting a firm commitment underwritten public offering of units, each consisting of one share of common stock and a five‑year warrant exercisable at 125% of the public offering price. The company will also register the common shares underlying these warrants and those issuable under a Representative’s Warrant. Net proceeds are allocated approximately 15% to sales and marketing, 40% to R&D and technology, 20% to expansion into ASEAN and US markets, 20% to vertical and horizontal integrations including M&A, with the balance for working capital and general corporate purposes.
As of March 31, 2026, Agape ATP reported current assets of $24,654,430, largely a $24,123,725 deposit with Bicheng Investment Management in China to source equity investments, where PRC foreign‑exchange rules could constrain any refund. For the three months ended March 31, 2026, revenue was $273,658 and net loss was $340,906, contributing to an accumulated deficit of $12,125,455 and management’s disclosure of substantial doubt about continuing as a going concern. The company also highlights risks related to future Nasdaq listing compliance, potential dilution from additional equity sales, and the possibility of losing part or all of the Bicheng deposit if it cannot be repatriated.
Agape ATP Corp’s institutional investor Jane Street Group, LLC, together with Jane Street Capital, LLC and Jane Street Global Trading, LLC, reports beneficial ownership of 50,238 shares of Agape ATP common stock, representing 5.0% of the class.
All 50,238 shares carry shared voting and dispositive power, with no sole voting or sole dispositive authority reported by the Jane Street entities.
Agape ATP Corporation is planning a primary public offering of units, with each unit consisting of one share of common stock and one five-year warrant to buy an additional share. The company is also registering the shares underlying these warrants and a representative’s warrant for the underwriter.
Its stock trades on the Nasdaq Capital Market under the symbol ATPC, with a recent closing price of $4.25 per share. Agape ATP operates mainly in Malaysia, selling health and wellness products through a network marketing model, and is expanding into renewable energy and digital wellness services across ASEAN and other markets.
Net proceeds are earmarked primarily for sales and marketing, research and technological development, regional and U.S. expansion, mergers and acquisitions in health services, and general working capital. The company has recently reported operating losses and carries a significant accumulated deficit, and its filings note substantial doubt about its ability to continue as a going concern without improved cash flow and additional financing.
Agape ATP Corporation reported Q1 2026 results with a smaller loss but continued financial strain. Revenue was $273,658, slightly below $289,037 a year earlier, while gross profit edged up to $159,409 as cost of revenue declined.
Operating expenses remained high at $836,781, leading to a loss from operations of $677,372. A large net exchange gain and marketable securities gains lifted total other income to $336,466, reducing net loss to $340,906 from $712,919. Cash was $220,779, but operating activities used $394,770 of cash.
The balance sheet shows total assets of $24.9M and equity of $22.1M, dominated by a $24.1M deposit with Bi Cheng Investment Management for future investments. Management states this investment is still unidentified and its financial return is uncertain, and discloses “substantial doubt” about the Company’s ability to continue as a going concern.
Agape ATP Corporation reports modest 2025 growth while highlighting significant operational and capital markets risks. Revenue rose about 15.2% to approximately $1.5 million, with gross profit up to roughly $0.8 million, driven by its Malaysian health and wellness network-marketing model and initial steps into renewable energy and digital wellness.
The company serves 56,465 distributors and 72,201 members, but relies heavily on a few Malaysian suppliers and has only 18 employees. Management discloses multiple material weaknesses in internal control over financial reporting, limited insurance coverage, concentrated supplier and regulatory risk, and exposure to shifting consumer preferences.
Agape also details substantial equity dilution: stockholders approved an increase in authorized common shares to 500 million and the issuance of 46 million new shares at $0.50 each. The report further warns that the company faces Nasdaq delisting risk due to a prolonged low share price and has already received Staff determinations requiring an appeal to maintain its listing.
Agape ATP Corporation notified the SEC it cannot timely file its Form 10-K for the year ended December 31, 2025 and expects to use the fifteen-day grace period under Rule 12b-25 to file. The delay is to obtain supporting documentation and allow the independent auditor to complete its audit.
The notification was signed by How Kok Choong on March 31, 2025. The company states this delay is due to additional time needed to complete audit procedures and collect documentation.
Agape ATP Corporation reported that Nasdaq has confirmed the company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company had previously received Nasdaq notices in January and February 2026 citing a bid price below $1.00 per share and a closing bid of $0.10 or less for ten consecutive trading days under the “Low Priced Stocks” rule.
Following the March 10, 2026 letter from the Nasdaq Hearings Advisor, the scheduled March 17, 2026 hearing has been cancelled, and the company’s common stock will continue trading on Nasdaq under the symbol ATPC.
Agape ATP Corporation, through its wholly owned subsidiary ATPC Green Energy Sdn. Bhd., has entered into a non-exclusive Collaboration Agreement with Citadel Investment LLC, a Dubai-based investment and global commodities trading firm, effective March 2026.
The parties plan to cooperate on the sale and purchase of oil, gas, refinery and petrochemical products by leveraging their respective commercial networks to identify, structure and facilitate cross-border energy transactions. The agreement outlines commission or profit-sharing for transactions introduced under the partnership and includes provisions on intellectual property, assignment, confidentiality, and protection of clients and business partners introduced by either party.
Agape ATP Corporation has filed a mixed shelf registration that allows it to offer and sell up to $200,000,000 of common stock, preferred stock, warrants and units over time. Actual terms, prices and amounts for each sale will be set in future prospectus supplements.
The company plans to use any proceeds for general corporate purposes, including marketing and e‑commerce for its health and wellness products, R&D and technology development, expansion into ASEAN and U.S. markets, strategic acquisitions in the wellness ecosystem, and working capital.
Agape operates primarily in Malaysia’s health and wellness sector through a direct-selling model, offering nutritional programs and complementary therapies, and is also developing renewable energy and digital wellness platforms. Its common stock trades on Nasdaq under the symbol ATPC.